What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?
Kemp AS, Schooler NR, Kalali AH, Alphs L, Anand R, Awad G, Davidson M, Dubé S, Ereshefsky L, Gharabawi G, Leon AC, Lepine JP, Potkin SG, Vermeulen A.
Kemp AS, et al. Among authors: potkin sg.
Schizophr Bull. 2010 May;36(3):504-9. doi: 10.1093/schbul/sbn110. Epub 2008 Aug 22.
Schizophr Bull. 2010.
PMID: 18723840
Free PMC article.